Search hospitals > Louisiana > New Orleans
Children's Hospital New Orleans
Claim this profileNew Orleans, Louisiana 70118
Global Leader in T-Lymphoblastic Leukemia/Lymphoma
Global Leader in Uterine Tumors
Conducts research for Lymphoma
Conducts research for Cancer
Conducts research for Acute Lymphoblastic Leukemia
211 reported clinical trials
4 medical researchers
Summary
Children's Hospital New Orleans is a medical facility located in New Orleans, Louisiana. This center is recognized for care of T-Lymphoblastic Leukemia/Lymphoma, Uterine Tumors, Lymphoma, Cancer, Acute Lymphoblastic Leukemia and other specialties. Children's Hospital New Orleans is involved with conducting 211 clinical trials across 393 conditions. There are 4 research doctors associated with this hospital, such as Lolie C. Yu, Augusto C. Ochoa, Jessica Gautreaux, and Christopher Roth.Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
Global LeaderStage II
Stage IV
Stage III
2Uterine Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Lolie C. YuChildren's Hospital New Orleans7 years of reported clinical research
Expert in Uterine Tumors
Expert in Cancer
64 reported clinical trials
116 drugs studied
Augusto C. OchoaLouisiana State University Health Science Center8 years of reported clinical research
Studies Skin Cancer
Studies Breast Cancer
19 reported clinical trials
75 drugs studied
Jessica GautreauxChildren's Hospital of New Orleans LCMC Health5 years of reported clinical research
Studies Migraine
2 reported clinical trials
1 drug studied
Christopher RothChildrens Hospital New Orleans2 years of reported clinical research
Studies Overactive Bladder
Studies Neurogenic Detrusor Overactivity
1 reported clinical trial
1 drug studied
Clinical Trials running at Children's Hospital New Orleans
Kidney Wilms Tumor
Testicular cancer
Acute Lymphoblastic Leukemia
Migraine
Uterine Tumors
T-Lymphoblastic Leukemia/Lymphoma
Wilms Tumor
Ovarian Tumors
Ovarian Choriocarcinoma
Ovarian Carcinoma
Various Treatments
for Wilms Tumor
This phase III trial studies using risk factors in determining treatment for children with favorable tissue (histology) Wilms tumors (FHWT). Wilms Tumor is the most common type of kidney cancer in children, and FHWT is the most common subtype. Previous large clinical trials have established treatment plans that are likely to cure most children with FHWT, however some children still have their cancer come back (called relapse) and not all survive. Previous research has identified features of FHWT that are associated with higher or lower risks of relapse. The term "risk" refers to the chance of the cancer coming back after treatment. Using results of tumor histology tests, biology tests, and response to therapy may be able to improve treatment for children with FHWT.
Recruiting2 awards Phase 34 criteria
Chemotherapy
for Wilms Tumor
This phase II trial studies how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FHWT) that have come back (relapsed). Drugs used in chemotherapy regimens such as UH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, and irinotecan) and ICE/Cyclo/Topo (ifosfamide, carboplatin, etoposide, cyclophosphamide, and topotecan) work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out what effects, good and/or bad, regimen UH-3 has on patients with newly diagnosed DAWT and standard risk relapsed FHWT (those treated with only 2 drugs for the initial WT) and regimen ICE/Cyclo/Topo has on patients with high and very high risk relapsed FHWT (those treated with 3 or more drugs for the initial WT).
Recruiting1 award Phase 212 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Children's Hospital New Orleans?
Children's Hospital New Orleans is a medical facility located in New Orleans, Louisiana. This center is recognized for care of T-Lymphoblastic Leukemia/Lymphoma, Uterine Tumors, Lymphoma, Cancer, Acute Lymphoblastic Leukemia and other specialties. Children's Hospital New Orleans is involved with conducting 211 clinical trials across 393 conditions. There are 4 research doctors associated with this hospital, such as Lolie C. Yu, Augusto C. Ochoa, Jessica Gautreaux, and Christopher Roth.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.